Predict your next investment

Government
BUSINESS PRODUCTS & SERVICES
ec.europa.eu/programmes/horizon2020/en

See what CB Insights has to offer

Investments

1225

Portfolio Exits

99

Partners & Customers

1

About Horizon 2020

Horizon 2020 is an EU research and Innovation program with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract.

Horizon 2020 Headquarter Location

Brussels,

Belgium

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Horizon 2020

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Horizon 2020 in 1 Expert Collection, including Beauty & Personal Care.

B

Beauty & Personal Care

58 items

Startups in the beauty & personal care space, including cosmetics brands, shaving startups, on-demand beauty services, salon management platforms, and more.

Horizon 2020 Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Horizon 2020 Rank

Latest Horizon 2020 News

Global Biosimilars Partnering Terms and Agreements 2010 to 2022: Featuring Boston Oncology, Concord Biosciences, Horizon 2020 & More - ResearchAndMarkets.com

Jun 24, 2022

This report is intended to provide the reader with an in-depth understanding and access to Biosimilars trends and structure of deals entered into by leading companies worldwide. The report provides a detailed understanding and analysis of how and why companies enter Biosimilars partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors Biosimilars technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not. This report contains links to online copies of actual Biosimilars deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Global Biosimilars Partnering Terms and Agreements 2010 to 2022 includes: Trends in Biosimilars dealmaking in the biopharma industry since 2010 Access to headline, upfront, milestone and royalty data Access to over 190 Biosimilars deal records and contract documents where available The leading Biosimilar deals by value since 2010 Most active Biosimilars dealmakers since 2010 The leading Biosimilars partnering resources Key Topics Covered:

Horizon 2020 Investments

1,225 Investments

Horizon 2020 has made 1,225 investments. Their latest investment was in Octavic as part of their Grant on June 6, 2022.

CBI Logo

Horizon 2020 Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/13/2022

Grant

Octavic

$0.8M

Yes

1

3/3/2022

Grant

Waste2Func

$7.4M

Yes

1

8/26/2021

Grant - III

Sleepiz

$3.26M

No

1

7/27/2021

Seed VC

Subscribe to see more

Subscribe to see more

10

7/22/2021

Grant

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/13/2022

3/3/2022

8/26/2021

7/27/2021

7/22/2021

Round

Grant

Grant

Grant - III

Seed VC

Grant

Company

Octavic

Waste2Func

Sleepiz

Subscribe to see more

Subscribe to see more

Amount

$0.8M

$7.4M

$3.26M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Horizon 2020 Portfolio Exits

99 Portfolio Exits

Horizon 2020 has 99 portfolio exits. Their latest portfolio exit was eLEAF on May 25, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/25/2022

Corporate Majority

$99M

1

5/5/2022

Acq - Fin

$99M

2

5/5/2022

Acquired

$99M

1

5/3/2022

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

3/29/2022

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/25/2022

5/5/2022

5/5/2022

5/3/2022

3/29/2022

Exit

Corporate Majority

Acq - Fin

Acquired

Corporate Majority

Corporate Majority

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Horizon 2020 Partners & Customers

1 Partners and customers

Horizon 2020 has 1 strategic partners and customers. Horizon 2020 recently partnered with Euformatics on October 10, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

10/25/2018

Vendor

Finland

ESPOO, Finland, October, 2018. Euformatics selected for GEMMA H2020 project to provide genomics analysis and quality control for Autism Spectrum Disorders

Euformatics selected for GEMMA project to provide genomics analysis and quality control for Autism Spectrum Disorders .

2

Date

10/25/2018

Type

Vendor

Business Partner

Country

Finland

News Snippet

ESPOO, Finland, October, 2018. Euformatics selected for GEMMA H2020 project to provide genomics analysis and quality control for Autism Spectrum Disorders

Euformatics selected for GEMMA project to provide genomics analysis and quality control for Autism Spectrum Disorders .

Sources

2

Horizon 2020 Team

1 Team Member

Horizon 2020 has 1 team member, including current General Partner, Robert-Jan Smits.

Name

Work History

Title

Status

Robert-Jan Smits

General Partner

Current

Name

Robert-Jan Smits

Work History

Title

General Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.